Singapore News
-
IBN engineered artificial human liver for drug testing
Singapore | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: The liver is an important target organ for drug testing because all drugs pass through it for detoxification. This is a process whereby harmful substances are reduced or removed...Read more
-
A*STAR, GSK develop medicines for emerging markets
Singapore | News | By BioSpectrum Bureau | 0 Comment | 09 Apr, 2013
Singapore: GlaxoSmithKline (GSK) and A*STAR's Institute of Chemical and Engineering Sciences (ICES) have signed a five-year strategic agreement to develop new evidence based formulations (E...Read more
-
Austrianova strengthens its Thailand operations
Singapore | News | By BioSpectrum Bureau | 0 Comment | 20 Jun, 2014
Singapore: Singapore based biotechnology firm, Austrianova, has received Board of Investment (BOI) status for its Thai subsidiary. BOI is a Thai government agency designed to assist compani...Read more
-
Singapore's R&D reached new high in 2011
Singapore | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Singapore's gross expenditure on R&D (GERD) recorded a new high of S$7.4 billion in 2011, according to the National Survey of R&D, 2011, produced by the Agency for Scien...Read more
-
A*Star develops microscale epigenomics technology
Singapore | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Scientists at A*STAR's Genome Institute of Singapore (GIS) have successfully developed a method to map the epigenome using 100 times fewer cells than was previously possible. The...Read more
-
Scientists identify new biomarker for cancer
Singapore | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Scientists from Singapore have identified FAIM, a molecule that typically prevents cell death, as a potential biomarker to identify an incurable form of cancer in the bone marrow...Read more
-
Singapore opens window for Korea medtech firms
Singapore | News | By BioSpectrum Bureau | 0 Comment | 20 Jun, 2014
Singapore: Singapore's Agency for Science, Technology and Research (A*STAR) and Korean Health Industry Development Institute (KHIDI) have come together to jointly develop medical technologi...Read more
-
Asia goes paperless for patient records
Singapore | Analysis | By BioSpectrum Bureau | 0 Comment | 29 Nov, 2012
The rising demand for cost containment in healthcare and the need to improve quality of services are driving the growth of the electronic medical records (EMR) market around the world. Acco...Read more
-
Telecom services to boom in APAC healthcare sector: Report
Singapore | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Telecommunication companies in Asia-Pacific are increasingly exploring vertical markets like healthcare to open up new revenue streams as the market holds great potential for tel...Read more
-
Mundipharma, Shionogi tie up for pain treatment in Japan
Singapore | News | By BioSpectrum Bureau | 0 Comment | 22 Nov, 2013
Singapore: Mundipharma has entered a license agreement with Japan-based Shionogi for the exclusive rights to develop, manufacture and commercialize the abuse deterrent formulation of Oxycod...Read more
-
A*STAR scientists identify potential drug target for inflammatory diseases including cancers
Singapore | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: A*STAR scientists have identified the enzyme, telomerase, as a cause of chronic inflammation in human cancers. Chronic inflammation is now recognized as a key underlying cause f...Read more
-
Mesoblast to set up stem cell drug plant in Singapore
Singapore | News | By BioSpectrum Bureau | 0 Comment | 29 May, 2014
Singapore: Australian regenerative drug company, Mesoblast, is planning to expand its global manufacturing base and the company is in dialogues with Singapore Economic Development Board (ED...Read more
-
Boehringer heart drug is particularly effective in Asian population
Singapore | News | By BioSpectrum Bureau | 0 Comment | 13 Sep, 2012
Singapore: Boehringer Ingelheim has reported that in Asian populations, Pradaxa (dabigatran etexilate) offers considerable benefits for the management of patients with atrial fibrillation (...Read more
-
Covance expands Singapore drug development lab
Singapore | News | By BioSpectrum Bureau | 0 Comment | 17 Apr, 2013
Singapore: Covance expanded its central laboratory facility in Singapore to enhance the company's current service offerings and position it to meet current and future growth of drug develop...Read more
-
IME, SFC Fluidics xollaborate to develop traumatic brain injury diagnostic device
Singapore | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: A*STAR's Institute of Microelectronics (IME) and SFC Fluidics, a USA microfluidics-based biomedical device development company, will be collaborating to develop a portable diagn...Read more
-
BioSingapore appoints Quintiles director as chairman
Singapore | News | By BioSpectrum Bureau | 0 Comment | 10 Oct, 2012
Singapore: Biomedical association of Singapore, BioSingapore has appointed Mr Simranjit Singh, director, strategic planning Asia, Quintiles, as its new chairman. In his new role, Mr Singh ...Read more
-
Singapore | News | By BioSpectrum Bureau | 0 Comment | 21 Jun, 2013
Singapore: A team of National University of Singapore (NUS) researchers from Departments of Bioengineering and Orthopaedic Surgery has developed a three-dimensional (3D) tumor model. As it ...Read more
-
Singapore invests $17 mn in synthetic biology
Singapore | News | By BioSpectrum Bureau | 0 Comment | 30 Sep, 2015
Singapore: National University of Singapore (NUS) has taken a new research initiative called the NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI) to develop research...Read more
